Bain Capital Specialty Finance , Inc. (NYSE:BCSF), a specialty finance company with a market capitalization of $1.17 billion and trading near its 52-week high of $18.35, announced the issuance of $350 ...
At this time, I would like to welcome everyone to the SelectQuote's fiscal second quarter 2025 earnings call. All lines have ...
Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes and cancer with “precision medicine”. Leverage the power of TipRanks ...
TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment ... MTPC is focusing on “precision medicine” to provide drugs with high treatment satisfaction by identifying ...
Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment Founded in 1678 ...
“Milacron is an iconic American manufacturing business with a 50-year legacy of driving innovation in plastics,” said Matt Evans, a partner at Bain Capital Special Situations in a statement.
Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...
Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It is a new position. Largay oversees the team’s debt and financing ...
Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.
Boston-based Bain Capital hired a JLL senior leader as its head of real estate capital markets. Keith Largay has taken the role at the investment firm, Bain announced in a LinkedIn post.
Private equity firm Bain Capital agreed to acquire Mitsubishi ... In a time of both misinformation and too much information, quality journalism is more crucial than ever. By subscribing, you ...